Table 5.

Analysis of microglial process accumulation based on repeated-measures ANOVAs conducted at each distance from the CMB with condition (diabetic + vehicle and diabetic + IFNγ-blocking IgG) as a factor over time (0–60 min)

Distance	Condition	Time	Interaction
5–10 μm	F(1,15) = 0.38, p = 0.54	F(15,270) = 67.65, p < 0.001*	F(15,270) = 0.73, p = 0.74
10–15 μm	F(1,15) = 0.39, p = 0.53	F(15,270) = 31.47, p < 0.001*	F(15,270) = 0.57, p = 089
15–20 μm	F(1,15) = 6.85, p < 0.05*	F(15,270) = 23.63, p < 0.001*	F(15,270) = 3.44, p < 0.001*
20–25 μm	F(1,15) = 9.08, p < 0.01*	F(15,270) = 13.00, p < 0.001*	F(15,270) = 1.50, p = 0.11
25–30 μm	F(1,15) = 5.92, p < 0.05*	F(15,270) = 7.37, p < 0.001*	F(15,270) = 1.04, p = 0.41
30–35 μm	F(1,15) = 6.23, p < 0.05*	F(15,270) = 2.97, p < 0.001*	F(15,270) = 0.77, p = 0.71

*Significant main effects.